BridgeBio Pharma
BBIO
$27.83
Share price
0.32%
Change (1 day)
103.44%
Change (1 year)
Categories
BridgeBio Pharma (BBIO) - P/B ratio
P/B ratio as of May 2024 : -3.88
According to BridgeBio Pharma
's latest financial reports the company has a price-to-book ratio of -3.88.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
BridgeBio Pharma - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -5.23 | 471.74% |
| 2022-12-31 | -0.9150 | -67.74% |
| 2021-12-31 | -2.84 | -103.51% |
| 2020-12-31 | 80.9 | 788.16% |
| 2019-12-31 | 9.11 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -116.81% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -150.50% | 🇺🇸 USA |